NRG Oncology launches colorectal cancer prevention study

Research company NRG Oncology has launched a study to examine patients with a first-diagnosis of adenomas, News-Medical.net reported Oct. 6.

Advertisement

The purpose of the study is to determine when patients diagnosed with one or two adenomas should have a repeat colonoscopy exam.

Researchers expect to enroll 9,500 participants, with 4,750 people in each study group. One study group will be assigned to have their next colonoscopies in five and 10 years, and the other will be assigned to their next colonoscopy in 10 years. Study participants will also be asked to give researchers blood, stool and tissue samples from polyps.

Robert Schoen, MD, chief of the division of gastroenterology, hepatology and nutrition at the University of Pittsburgh department of medicine, is principal investigator of the study.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Unlocking Structural Heart Capacity: How Leading Programs Use EMR and Data to Improve Patient Flow and Throughput

Wednesday, August 19
11:00 AM - 12:00 PM CDT

Presenters: Katie Kennedy, MSN, APRN, NP-C, Community Heart and VascularMisty Theriot, BSN, RN, CPHQ, FACC, Lake Charles Memorial Health SystemKatie Worthington, DNP, RN, Atlantic Health SystemTaryn Shipley, MBA, CSSBB, Lean HealthTech

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.